Recent Research Analysts’ Ratings Updates for GE HealthCare Technologies (GEHC)

GE HealthCare Technologies (NASDAQ: GEHC) has recently received a number of price target changes and ratings updates:

• 5/6/2025 – GE HealthCare Technologies had its price target lowered by analysts at Morgan Stanley from $86.00 to $78.00. They now have an “equal weight” rating on the stock.
• 5/5/2025 – GE HealthCare Technologies was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $73.00 price target on the stock, down previously from $74.00.
• 5/1/2025 – GE HealthCare Technologies had its price target lowered by analysts at Wells Fargo & Company from $103.00 to $89.00. They now have an “overweight” rating on the stock.
• 5/1/2025 – GE HealthCare Technologies had its price target lowered by analysts at Evercore ISI from $96.00 to $85.00. They now have an “outperform” rating on the stock.
• 5/1/2025 – GE HealthCare Technologies had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $94.00 to $82.00. They now have a “buy” rating on the stock.
• 4/30/2025 – GE HealthCare Technologies had its price target lowered by analysts at Citigroup Inc. from $105.00 to $86.00. They now have a “buy” rating on the stock.
• 4/23/2025 – GE HealthCare Technologies had its price target lowered by analysts at Piper Sandler from $104.00 to $88.00. They now have an “overweight” rating on the stock.
• 4/14/2025 – GE HealthCare Technologies was given a new $95.00 price target on by analysts at BTIG Research. They now have a “buy” rating on the stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $69.58 on Thursday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company’s 50-day moving average is $70.62 and its 200 day moving average is $79.89. The company has a market capitalization of $31.86 billion, a price-to-earnings ratio of 16.07, a price-to-earnings-growth ratio of 3.19 and a beta of 1.21. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. During the same period in the prior year, the firm posted $0.90 EPS. GE HealthCare Technologies’s revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were given a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.20%. The ex-dividend date was Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.95%.

Institutional Trading of GE HealthCare Technologies

Several institutional investors have recently bought and sold shares of the company. N.E.W. Advisory Services LLC purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at about $25,000. CoreFirst Bank & Trust purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $25,000. Bogart Wealth LLC raised its position in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after buying an additional 247 shares during the last quarter. Runnymede Capital Advisors Inc. purchased a new stake in GE HealthCare Technologies in the 4th quarter worth $28,000. Finally, Stonebridge Financial Group LLC lifted its position in shares of GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after buying an additional 222 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.